Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Palisade Bio Inc | Donald A. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 1,498,900 | 1,509,628 | - | - | Common Stock | |
| ESAB Corp | Mitchell P. Rales | Director, Executive Chair of Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 1,200,000 | 1,200,000 | - | - | Stock Option (right to buy) | |
| Cosmos Health Inc | Grigorios Siokas | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.23 per share. | 10 Jun 2026 | 701,447 | 13,263,361 | - | 0.2 | 160,000 | Common Stock, par value $.001 |
| Digital Brands Grp Inc | John Hilburn Davis | Director, CEO | Purchase of securities on an exchange or from another person at price $ 1.13 per share. | 10 Jun 2026 | 618,333 | 688,461 | - | 1.1 | 698,716 | Common Stock |
| Palisade Bio Inc | Binxian Wei | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 592,300 | 593,155 | - | - | Common Stock | |
| Palisade Bio Inc | Emil Chuang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 592,300 | 592,300 | - | - | Common Stock | |
| ESAB Corp | Shyam P. Kambeyanda | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 580,552 | 580,552 | - | - | Performance Stock Option (right to buy) | |
| Levi Strauss & Co. - Ordinary Shares Cls A | Robert D. Haas | Ten Percent Owner | 10 Jun 2026 | 488,851 | 25,243,695 | - | - | Class B Common Stock | ||
| Levi Strauss & Co. - Ordinary Shares Cls A | Robert D. Haas | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 24.10 per share. | 10 Jun 2026 | 488,851 | 0 (0%) | 0% | 24.1 | 11,783,753 | Class A Common Stock |
| Levi Strauss & Co. - Ordinary Shares Cls A | Robert D. Haas | Ten Percent Owner | 10 Jun 2026 | 488,851 | 488,851 (0%) | 0% | 0 | Class A Common Stock | ||
| Samsara Inc (Class A) | Marc L. Andreessen | Director | Sale of securities on an exchange or to another person at price $ 32.18 per share. | 10 Jun 2026 | 468,751 | 2,401,396 | - | 32.2 | 15,083,985 | Class A Common Stock |
| Oportun Fin Corp | Douglas K. Bland | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 463,822 | 463,822 (1%) | 1% | - | Common Stock | |
| Oportun Fin Corp | Douglas K. Bland | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 463,822 | 463,822 | - | - | Performance Stock Units | |
| Dutch Bros Inc (Class A) | Travis Boersma | Director, Executive Chairman of Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 60.35 per share. | 10 Jun 2026 | 461,532 | 5,030,988 | - | 60.4 | 27,854,748 | Class A Common Stock |
| Mistras Grp Inc | Aspasia Felice Vahaviolos | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jun 2026 | 411,875 | 1,794,839 (6%) | 1% | 0 | Common Stock | |
| Getty Images Holdings Inc (Class A) | Craig Peters | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 400,000 | 1,689,548 | - | 0 | Class A Common Stock | |
| Palisade Bio Inc | Jordan Michael Zwick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 336,904 | 336,904 | - | - | Common Stock | |
| Palisade Bio Inc | Robert F. Baltera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 336,904 | 336,904 | - | - | Common Stock | |
| Samsara Inc (Class A) | Marc L. Andreessen | Director | Sale of securities on an exchange or to another person at price $ 34.11 per share. | 10 Jun 2026 | 331,194 | 2,870,147 | - | 34.1 | 11,296,829 | Class A Common Stock |
| Eloxx Pharma | Sumit Aggarwal | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 328,833 | 328,833 | - | - | Stock Option (Right to Buy) | |
| Fortune Brands Innovations Inc | Edward P. Garden | Director | Purchase of securities on an exchange or from another person at price $ 40.60 per share. | 10 Jun 2026 | 320,067 | 3,940,234 (2%) | 0% | 40.6 | 12,994,720 | Common Stock, Par Value $0.01 |
| Dutch Bros Inc (Class A) | Travis Boersma | Director, Executive Chairman of Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 60.34 per share. | 10 Jun 2026 | 247,456 | 2,685,453 | - | 60.3 | 14,930,555 | Class A Common Stock |
| Dutch Bros Inc (Class A) | Travis Boersma | Director, Executive Chairman of Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 62.47 per share. | 10 Jun 2026 | 233,690 | 4,769,885 | - | 62.5 | 14,598,755 | Class A Common Stock |
| Dutch Bros Inc (Class A) | Travis Boersma | Director, Executive Chairman of Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 63.46 per share. | 10 Jun 2026 | 226,120 | 4,543,765 | - | 63.5 | 14,348,897 | Class A Common Stock |
| Alignment Healthcare Inc | John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 20.60 per share. | 10 Jun 2026 | 223,064 | 1,386,766 | - | 20.6 | 4,594,271 | Common Stock |
| Sensei Biotherapeutics Inc | Christopher W Gerry | President & PEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 220,000 | 220,000 | - | - | Stock Option (right to buy) | |
| Nerdy Inc (Class A) | Charles Cohn | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.91 per share. | 10 Jun 2026 | 219,019 | 219,019 | - | 0.9 | 199,307 | Class A Common Stock |
| Biomea Fusion Inc | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 196,299 | 196,299 | - | - | Stock Option (Right to Buy) | |
| Biomea Fusion Inc | Elizabeth Faust | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 196,299 | 196,299 | - | - | Stock Option (Right to Buy) | |
| Biomea Fusion Inc | Sumita Ray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 196,299 | 196,299 | - | - | Stock Option (Right to Buy) | |
| Slide Insurance Holdings Inc | Bruce Lucas | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 17.03 per share. | 10 Jun 2026 | 192,695 | 34,550,666 | - | 17.0 | 3,281,596 | Common Stock |
| Samsara Inc (Class A) | Marc L. Andreessen | Director | Sale of securities on an exchange or to another person at price $ 32.83 per share. | 10 Jun 2026 | 168,806 | 3,201,341 | - | 32.8 | 5,541,665 | Class A Common Stock |
| Samsara Inc (Class A) | Marc L. Andreessen | Director | Sale of securities on an exchange or to another person at price $ 32.56 per share. | 10 Jun 2026 | 144,909 | 2,256,487 | - | 32.6 | 4,717,875 | Class A Common Stock |
| Krispy Kreme Inc | Joshua A. Charlesworth | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 128,206 | 1,155,035 | - | 0 | Common Stock | |
| Dutch Bros Inc (Class A) | Travis Boersma | Director, Executive Chairman of Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 62.47 per share. | 10 Jun 2026 | 124,771 | 2,547,084 | - | 62.5 | 7,794,519 | Class A Common Stock |
| Dutch Bros Inc (Class A) | Travis Boersma | Director, Executive Chairman of Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 63.46 per share. | 10 Jun 2026 | 120,729 | 2,426,355 | - | 63.5 | 7,661,100 | Class A Common Stock |
| CubeSmart | Christopher P. Marr | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.30 per share. | 10 Jun 2026 | 108,932 | 718,537 (0%) | 0% | 26.3 | 2,864,912 | Common |
| CubeSmart | Christopher P. Marr | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 108,932 | 0 | - | - | Stock Option (right to buy) | |
| CubeSmart | Christopher P. Marr | Director, CEO | Sale of securities on an exchange or to another person at price $ 42.24 per share. | 10 Jun 2026 | 108,932 | 609,605 (0%) | 0% | 42.2 | 4,601,625 | Common |
| Liquidia Corp | Stephen Bloch | Director | Sale of securities on an exchange or to another person at price $ 65.54 per share. | 10 Jun 2026 | 103,301 | 1,446,690 (5%) | 0% | 65.5 | 6,770,585 | Common Stock |
| Gen Digital | Ondrej Vlcek | Director | Sale of securities on an exchange or to another person at price $ 24.78 per share. | 10 Jun 2026 | 100,000 | 3,832,724 (0%) | 0% | 24.8 | 2,478,300 | Common Stock |
| Krispy Kreme Inc | Raphael Duvivier | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 96,154 | 646,268 | - | 0 | Common Stock | |
| Liquidia Corp | Stephen Bloch | Director | Sale of securities on an exchange or to another person at price $ 71.74 per share. | 10 Jun 2026 | 92,128 | 1,176,870 (4%) | 0% | 71.7 | 6,609,309 | Common Stock |
| Yext Inc | Daniel J. Englander | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 86,419 | 86,419 | - | - | Restricted Stock Unit | |
| Liquidia Corp | Stephen Bloch | Director | Sale of securities on an exchange or to another person at price $ 69.87 per share. | 10 Jun 2026 | 85,285 | 1,289,206 (4%) | 0% | 69.9 | 5,959,204 | Common Stock |
| Centene | Kenneth A. Burdick | Director | Sale of securities on an exchange or to another person at price $ 64.55 per share. | 10 Jun 2026 | 80,000 | 197,085 (0%) | 0% | 64.6 | 5,164,000 | Common Stock |
| SKYX Platforms Corp | Dov Shiff | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jun 2026 | 80,000 | 1,432,952 (2%) | 0% | 0 | Common Stock, no par value | |
| SKYX Platforms Corp | Dov Shiff | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jun 2026 | 80,000 | 120,000 (0%) | 0% | 0 | Common Stock, no par value | |
| Solid Biosciences Inc | Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 77,500 | 77,500 | - | - | Director Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Sukumar Nagendran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 77,500 | 77,500 | - | - | Director Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Martin Freed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 77,500 | 77,500 | - | - | Director Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Ilan Ganot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 77,500 | 77,500 | - | - | Director Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Adam Stone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 77,500 | 77,500 | - | - | Director Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Lynne Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 77,500 | 77,500 | - | - | Director Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 77,500 | 77,500 | - | - | Director Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Clare Kahn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 77,500 | 77,500 | - | - | Director Stock Option (Right to Buy) | |
| Milestone Pharma Inc | Joseph C. Papa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 77,000 | 77,000 | - | - | Stock Option (right to buy) | |
| Milestone Pharma Inc | Lisa M. Giles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 77,000 | 77,000 | - | - | Stock Option (right to buy) | |
| Milestone Pharma Inc | Michael J. Tomsicek | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 77,000 | 77,000 | - | - | Stock Option (right to buy) | |
| Milestone Pharma Inc | Seth H.Z. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 77,000 | 77,000 | - | - | Stock Option (right to buy) | |
| Milestone Pharma Inc | Andrew R. Saik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 77,000 | 77,000 | - | - | Stock Option (right to buy) | |
| Milestone Pharma Inc | Robert J. Wills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 77,000 | 77,000 | - | - | Stock Option (right to buy) | |
| Milestone Pharma Inc | Stuart M. Duty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 77,000 | 77,000 | - | - | Stock Option (right to buy) | |
| Krispy Kreme Inc | Atiba D. Adams | CLO & Corporate Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 76,924 | 273,858 | - | 0 | Common Stock | |
| Krispy Kreme Inc | Alison Holder | Chief Brand & Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 76,924 | 399,305 | - | 0 | Common Stock | |
| Krispy Kreme Inc | Nicola J. Steele | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 76,924 | 388,858 | - | 0 | Common Stock | |
| MeiraGTx Holdings PLC | Keith R. Harris | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 75,000 | 0 | - | - | Restricted Share Units | |
| MeiraGTx Holdings PLC | Keith R. Harris | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 75,000 | 200,000 (0%) | 0% | - | Ordinary Shares | |
| SmartRent Inc (Class A) | Thomas N. Bohjalian | Director | Purchase of securities on an exchange or from another person at price $ 1.11 per share. | 10 Jun 2026 | 75,000 | 721,062 | - | 1.1 | 83,250 | Class A Common Stock |
| Alignment Healthcare Inc | John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 19.65 per share. | 10 Jun 2026 | 74,936 | 1,609,830 | - | 19.6 | 1,472,350 | Common Stock |
| Repay Holdings Corp (Class A) | Peter J. Kight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 73,964 | 1,744,034 (4%) | 0% | 0 | Class A Common Stock | |
| Zevia PBC (Class A) | Padraic L. Spence | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 72,464 | 1,627,881 | - | 0 | Class A Common Stock | |
| Zevia PBC (Class A) | Julie Garcia Ruehl | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 72,464 | 334,432 | - | 0 | Class A Common Stock | |
| Zevia PBC (Class A) | Alexandre I. Ruberti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 72,464 | 201,277 | - | 0 | Class A Common Stock | |
| Zevia PBC (Class A) | Andrew Ruben | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 72,464 | 299,432 | - | 0 | Class A Common Stock | |
| Zevia PBC (Class A) | Suzanne Saltzman Ginestro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 72,464 | 101,969 | - | 0 | Class A Common Stock | |
| Clean Energy Fuels Corp | Andrew J. Littlefair | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 67,839 | 1,982,832 (0%) | 0% | 0 | Common Stock | |
| Clean Energy Fuels Corp | Lizabeth A. Ardisana | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 67,839 | 166,126 (0%) | 0% | 0 | Common Stock | |
| Clean Energy Fuels Corp | Vincent C. Taormina | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 67,839 | 423,144 (0%) | 0% | 0 | Common Stock | |
| Clean Energy Fuels Corp | Vincent C. Taormina | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jun 2026 | 67,839 | 0 (0%) | 0% | 0 | Common Stock | |
| Clean Energy Fuels Corp | Vincent C. Taormina | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 67,839 | 67,839 (0%) | 0% | 0 | Common Stock | |
| Clean Energy Fuels Corp | Stephen A. Scully | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 67,839 | 335,244 (0%) | 0% | 0 | Common Stock | |
| Clean Energy Fuels Corp | Stephen A. Scully | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 67,839 | 67,839 (0%) | 0% | 0 | Common Stock | |
| Clean Energy Fuels Corp | Stephen A. Scully | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jun 2026 | 67,839 | 0 (0%) | 0% | 0 | Common Stock | |
| Clean Energy Fuels Corp | Patrick J. Ford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 67,839 | 126,799 (0%) | 0% | 0 | Common Stock | |
| Marqeta Inc (Class A) | Judson C. Linville | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 65,274 | 65,274 | - | - | Restricted Stock Units | |
| Kopin Corp | Margaret K. Seif | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 64,500 | 193,500 (0%) | 0% | 0 | Common Stock | |
| Kopin Corp | Paul V. Walsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 64,500 | 193,500 (0%) | 0% | 0 | Common Stock | |
| Kopin Corp | David J. Nieuwsma | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 64,500 | 258,000 (0%) | 0% | 0 | Common Stock | |
| Kopin Corp | Jill J. Avery | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 64,500 | 223,500 (0%) | 0% | 0 | Common Stock | |
| Krispy Kreme Inc | Bernardo Hees | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 64,103 | 149,516 | - | 0 | Common Stock | |
| Krispy Kreme Inc | Patricia Capel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 64,103 | 155,850 | - | 0 | Common Stock | |
| Datavault AI Inc | Stanley Mbugua | See Remarks | Sale of securities on an exchange or to another person at price $ 0.41 per share. | 10 Jun 2026 | 62,982 | 2,052,846 (8%) | 0% | 0.4 | 25,615 | Common Stock |
| Local Bounti Corp (Class A) | Mark J. Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 62,949 | 139,867 | - | 0 | Common Stock | |
| Local Bounti Corp (Class A) | Pamela Brewster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 62,949 | 266,124 | - | 0 | Common Stock | |
| Local Bounti Corp (Class A) | Matthew Nordby | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 62,949 | 163,654 | - | 0 | Common Stock | |
| Local Bounti Corp (Class A) | Michael Molnar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 62,949 | 176,291 | - | 0 | Common Stock | |
| Local Bounti Corp (Class A) | Charles R. Schwab | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 62,949 | 606,699 | - | 0 | Common Stock | |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | 10 Jun 2026 | 61,539 | 5,175,152 | - | - | Class B Common Stock | ||
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | 10 Jun 2026 | 61,539 | 61,539 | - | - | Class A Common Stock | ||
| Palisade Bio Inc | Donald A. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 60,666 | 121,334 | - | - | Restricted Stock Units | |
| Palisade Bio Inc | Donald A. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 60,666 | 1,570,294 | - | - | Common Stock | |
| Kore Grp Holdings Inc | H. Paulett Eberhart | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 58,139 | 139,705 | - | 0 | Common Stock | |
| Kore Grp Holdings Inc | H. Paulett Eberhart | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 58,139 | 0 | - | - | Restricted Stock Units | |
| Kore Grp Holdings Inc | Cheemin Bo-Linn | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 58,139 | 0 | - | - | Restricted Stock Units | |
| Kore Grp Holdings Inc | Cheemin Bo-Linn | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 58,139 | 141,505 | - | 0 | Common Stock | |
| ESAB Corp | Curtis E. Jewell | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 58,056 | 58,056 | - | - | Performance Stock Option (right to buy) | |
| Procore Tech Inc | Craig F. Courtemanche | Director, Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.42 per share. | 10 Jun 2026 | 56,122 | 975,826 | - | 2.4 | 135,815 | Common Stock |
| Procore Tech Inc | Craig F. Courtemanche | Director, Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 56,122 | 224,488 | - | - | Stock Option (Right to Buy) | |
| Cytek BioSciences Inc | Glenn P. Muir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 55,555 | 55,555 | - | - | Restricted Stock Units | |
| ESAB Corp | Michele Campion | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 52,250 | 52,250 | - | - | Performance Stock Option (right to buy) | |
| Marqeta Inc (Class A) | Wendy K. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 52,219 | 52,219 | - | - | Restricted Stock Units | |
| Marqeta Inc (Class A) | Martha Cummings | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 52,219 | 52,219 | - | - | Restricted Stock Units | |
| Marqeta Inc (Class A) | Elaine Paul | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 52,219 | 52,219 | - | - | Restricted Stock Units | |
| Marqeta Inc (Class A) | Kiran Prasad | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 52,219 | 52,219 | - | - | Restricted Stock Units | |
| Marqeta Inc (Class A) | Alpesh Chokshi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 52,219 | 52,219 | - | - | Restricted Stock Units | |
| Mimedx Grp Inc | Dorothy E. Puhy | Director | Grant, award, or other acquisition of securities at price $ 3.64 per share. | 10 Jun 2026 | 50,913 | 108,510 (0%) | 0% | 3.6 | 185,323 | Common Stock |
| Mimedx Grp Inc | William A. Hawkins | Director | Grant, award, or other acquisition of securities at price $ 3.64 per share. | 10 Jun 2026 | 50,913 | 254,931 (0%) | 0% | 3.6 | 185,323 | Common Stock |
| Mimedx Grp Inc | James L. Bierman | Director | Grant, award, or other acquisition of securities at price $ 3.64 per share. | 10 Jun 2026 | 50,913 | 263,684 (0%) | 0% | 3.6 | 185,323 | Common Stock |
| Mimedx Grp Inc | Tiffany P. Olson | Director | Grant, award, or other acquisition of securities at price $ 3.64 per share. | 10 Jun 2026 | 50,913 | 108,510 (0%) | 0% | 3.6 | 185,323 | Common Stock |
| Mimedx Grp Inc | K. Todd Newton | Director | Grant, award, or other acquisition of securities at price $ 3.64 per share. | 10 Jun 2026 | 50,913 | 463,684 (0%) | 0% | 3.6 | 185,323 | Common Stock |
| Aquestive Therapeutics Inc | Gregory B. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 50,500 | 50,500 | - | - | Stock Option (Right to Purchase) | |
| Aquestive Therapeutics Inc | Timothy E. Morris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 50,500 | 50,500 | - | - | Stock Option (right to purchase) | |
| Aquestive Therapeutics Inc | Marco Taglietti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 50,500 | 50,500 | - | - | Stock Option (Right to Purchase) | |
| Aquestive Therapeutics Inc | Julie Krop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 50,500 | 50,500 | - | - | Stock Option (Right to Purchase) | |
| Aquestive Therapeutics Inc | John S. Cochran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 50,500 | 50,500 | - | - | Stock Option (Right to Purchase) | |
| Aquestive Therapeutics Inc | Abigail L. Jenkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 50,500 | 50,500 | - | - | Non-Qualified Stock Option (right to buy) | |
| Repay Holdings Corp (Class A) | Richard E. Thornburgh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 50,295 | 181,751 (0%) | 0% | 0 | Class A Common Stock | |
| Repay Holdings Corp (Class A) | Paul R. Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 50,295 | 230,951 (0%) | 0% | 0 | Class A Common Stock | |
| Repay Holdings Corp (Class A) | Maryann B. Goebel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 50,295 | 165,151 (0%) | 0% | 0 | Class A Common Stock | |
| Repay Holdings Corp (Class A) | Emnet Rios | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 50,295 | 147,398 (0%) | 0% | 0 | Class A Common Stock | |
| WSFS Fin Corp | Rodger Levenson | President & CEO | Sale of securities on an exchange or to another person at price $ 74.01 per share. | 10 Jun 2026 | 50,040 | 201,494 (0%) | 0% | 74.0 | 3,703,460 | Common Stock |
| Ibotta Inc (Class A) | Bryan Leach | Director, CEO AND PRESIDENT, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jun 2026 | 50,000 | 866,484 | - | 0 | Class A Common Stock | |
| Tigo Energy Inc | Joan C. Conley | Director | Sale of securities on an exchange or to another person at price $ 3.10 per share. | 10 Jun 2026 | 50,000 | 227,902 | - | 3.1 | 155,000 | Common Stock |
| Bumble Inc (Class A) | Whitney Wolfe Herd | Director, Chief Executive Officer, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.71 per share. | 10 Jun 2026 | 46,751 | 1,356,863 | - | 2.7 | 126,695 | Class A Common Stock |
| Arista Networks | Kenneth Duda | Director, President and CTO | Other type of transaction at price $ 0.00 per share. | 10 Jun 2026 | 45,875 | 756,272 (0%) | 0% | 0 | Common Stock | |
| Arista Networks | Kenneth Duda | Director, President and CTO | Other type of transaction at price $ 0.00 per share. | 10 Jun 2026 | 45,875 | 62,498 (0%) | 0% | 0 | Common Stock | |
| Marqeta Inc (Class A) | Judson C. Linville | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 45,372 | 0 | - | - | Restricted Stock Units | |
| Marqeta Inc (Class A) | Judson C. Linville | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 45,372 | 165,028 | - | 0 | Class A Common Stock | |
| Slide Insurance Holdings Inc | Bruce Lucas | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 17.12 per share. | 10 Jun 2026 | 44,467 | 34,506,199 | - | 17.1 | 761,275 | Common Stock |
| Ocular Therapeutix Inc | Adrienne L. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Merilee Raines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Richard L. Lindstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Charles Warden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Leslie J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Seung Suh Hong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
| Cytek BioSciences Inc | Deborah J. Neff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 43,973 | 59,679 | - | - | Common Stock | |
| Cytek BioSciences Inc | Deborah J. Neff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 43,973 | 0 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Michael Holder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 43,973 | 60,694 | - | - | Common Stock | |
| Cytek BioSciences Inc | Michael Holder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 43,973 | 0 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Jack Ball | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 43,973 | 86,678 | - | - | Common Stock | |
| Cytek BioSciences Inc | Jack Ball | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 43,973 | 0 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Vera Imper | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 43,973 | 0 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Vera Imper | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 43,973 | 59,679 | - | - | Common Stock | |
| Angi Inc (Class A) | Thomas R. Evans | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 43,936 | 43,936 | - | - | Restricted Stock Units | |
| Angi Inc (Class A) | Jeremy G. Philips | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 43,936 | 43,936 | - | - | Restricted Stock Units | |
| Angi Inc (Class A) | Alesia J. Haas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 43,936 | 43,936 | - | - | Restricted Stock Units | |
| Angi Inc (Class A) | Glenn H. Schiffman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 43,936 | 43,936 | - | - | Restricted Stock Units | |
| Angi Inc (Class A) | Suzy Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 43,936 | 43,936 | - | - | Restricted Stock Units | |
| Angi Inc (Class A) | Sandra Buchanan Hurse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 43,936 | 43,936 | - | - | Restricted Stock Units | |
| Angi Inc (Class A) | Thomas Corning Pickett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 43,936 | 43,936 | - | - | Restricted Stock Units | |
| Yext Inc | Andrew T. Sheehan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 43,209 | 199,583 (0%) | 0% | 0 | Common Stock | |
| Yext Inc | Hillary B. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 43,209 | 43,209 | - | - | Restricted Stock Unit | |
| Yext Inc | Seth H. Waugh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 43,209 | 43,209 | - | - | Restricted Stock Unit | |
| Yext Inc | Evan Skorpen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 43,209 | 43,209 | - | - | Restricted Stock Unit | |
| Yext Inc | Mark S. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 43,209 | 43,209 | - | - | Restricted Stock Unit | |
| Seadrill Ltd | Torsten Sauer-Petersen | See Remarks | Sale of securities on an exchange or to another person at price $ 44.68 per share. | 10 Jun 2026 | 42,625 | 0 | - | 44.7 | 1,904,485 | Common Shares |
| Procore Tech Inc | Craig F. Courtemanche | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 45.29 per share. | 10 Jun 2026 | 42,421 | 919,704 | - | 45.3 | 1,921,247 | Common Stock |
| Dutch Bros Inc (Class A) | Christine Barone | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 60.13 per share. | 10 Jun 2026 | 42,031 | 44,573 | - | 60.1 | 2,527,492 | Class A Common Stock |
| CS Disco Inc | Robert P. Goodman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 41,096 | 69,132 | - | 0 | Common Stock | |
| CS Disco Inc | Scott Anthony Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 41,096 | 264,326 | - | 0 | Common Stock | |
| CS Disco Inc | Susan L. Blount | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 41,096 | 135,919 | - | 0 | Common Stock | |
| CS Disco Inc | Thomas F. Bogan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 41,096 | 212,186 | - | 0 | Common Stock | |
| CS Disco Inc | James R. Offerdahl | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 41,096 | 264,748 | - | 0 | Common Stock | |
| Life Time Grp Holdings Inc | Jimena Almendares | Director | Sale of securities on an exchange or to another person at price $ 33.59 per share. | 10 Jun 2026 | 40,589 | 36,983 | - | 33.6 | 1,363,527 | Common Stock |
| Kiora Pharma Inc | Praveen Tyle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| LSB Ind Inc | Lynn F. White | Director | Sale of securities on an exchange or to another person at price $ 11.80 per share. | 10 Jun 2026 | 40,000 | 202,489 (0%) | 0% | 11.8 | 472,000 | Common Stock |
| Gyre Therapeutics Inc | Dan Weng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Gyre Therapeutics Inc | David M. Epstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Gyre Therapeutics Inc | Gordon G. Carmichael | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Gyre Therapeutics Inc | Renate Parry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Gyre Therapeutics Inc | Rodney L. Nussbaum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Gyre Therapeutics Inc | Ping Zhang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Krispy Kreme Inc | Melissa Alves Werneck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 39,653 | 39,653 | - | 0 | Common Stock | |
| Krispy Kreme Inc | David Chan Shear | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 39,653 | 39,653 | - | 0 | Common Stock | |
| Fortrea Holdings Inc | Edward A. Pesicka | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 38,817 | 52,453 | - | 0 | Common Stock | |
| Fortrea Holdings Inc | Edward A. Pesicka | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 38,817 | 0 | - | - | Restricted Stock Unit | |
| Fortrea Holdings Inc | Erin L. Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 38,817 | 0 | - | - | Restricted Stock Unit | |
| Fortrea Holdings Inc | Erin L. Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 38,817 | 72,617 | - | 0 | Common Stock | |
| Fortrea Holdings Inc | David R. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 38,817 | 0 | - | - | Restricted Stock Unit | |
| Fortrea Holdings Inc | David R. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 38,817 | 48,361 | - | 0 | Common Stock | |
| Fortrea Holdings Inc | Amrit Ray | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 38,817 | 0 | - | - | Restricted Stock Unit | |
| Fortrea Holdings Inc | Amrit Ray | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 38,817 | 52,453 | - | 0 | Common Stock | |
| Krispy Kreme Inc | Lori M. Suess | Head of People and Culture | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 38,462 | 149,405 | - | 0 | Common Stock | |
| Nkarta Inc | Leone D Patterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 37,000 | 37,000 | - | - | Stock Option (right to buy) | |
| Nkarta Inc | Simeon J. George | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 37,000 | 37,000 | - | - | Stock Option (right to buy) | |
| Nkarta Inc | Michael Dybbs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 37,000 | 37,000 | - | - | Stock Option (right to buy) | |
| Nkarta Inc | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 37,000 | 37,000 | - | - | Stock Option (right to buy) | |
| Nkarta Inc | Angela Thedinga | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 37,000 | 37,000 | - | - | Stock Option (right to buy) | |
| Nkarta Inc | Zachary Scheiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 37,000 | 37,000 | - | - | Stock Option (right to buy) | |
| Nkarta Inc | George Vratsanos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 37,000 | 37,000 | - | - | Stock Option (right to buy) | |
| NexPoint Diversified Real Estate Trust | James D. Dondero | Director, See Remarks, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 36,692 | 110,076 | - | - | Restricted Share Units | |
| NexPoint Diversified Real Estate Trust | James D. Dondero | Director, See Remarks, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 36,692 | 6,046,963 (13%) | 0% | - | Common Stock | |
| NexPoint Diversified Real Estate Trust | Matt McGraner | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 36,692 | 354,269 (0%) | 0% | - | Common Stock | |
| Marqeta Inc (Class A) | Wendy K. Thomas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 36,297 | 71,202 | - | 0 | Class A Common Stock | |
| Marqeta Inc (Class A) | Wendy K. Thomas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 36,297 | 0 | - | - | Restricted Stock Units | |
| Marqeta Inc (Class A) | Martha Cummings | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 36,297 | 0 | - | - | Restricted Stock Units | |
| Marqeta Inc (Class A) | Martha Cummings | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 36,297 | 66,707 | - | 0 | Class A Common Stock | |
| Marqeta Inc (Class A) | Elaine Paul | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 36,297 | 0 | - | - | Restricted Stock Units | |
| Marqeta Inc (Class A) | Elaine Paul | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 36,297 | 53,750 | - | 0 | Class A Common Stock | |
| Marqeta Inc (Class A) | Kiran Prasad | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 36,297 | 0 | - | - | Restricted Stock Units | |
| Marqeta Inc (Class A) | Kiran Prasad | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 36,297 | 162,634 | - | 0 | Class A Common Stock | |
| Marqeta Inc (Class A) | Alpesh Chokshi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 36,297 | 61,890 | - | 0 | Class A Common Stock | |
| Marqeta Inc (Class A) | Alpesh Chokshi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 36,297 | 0 | - | - | Restricted Stock Units | |
| WSFS Fin Corp | Rodger Levenson | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.11 per share. | 10 Jun 2026 | 34,740 | 223,804 (0%) | 0% | 36.1 | 1,254,461 | Common Stock |
| WSFS Fin Corp | Rodger Levenson | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 34,740 | 0 | - | - | Employee Stock Option (right to buy) | |
| Designer Brands Inc (Class A) | Mary Turner | EVP;Pres DesignerBrands Canada | Sale of securities on an exchange or to another person at price $ 7.00 per share. | 10 Jun 2026 | 34,708 | 601 (0%) | 0% | 7.0 | 242,838 | Class A Common Shares |
| Circle Internet Grp Inc (Class A) | Hossein Razzaghi | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 78.85 per share. | 10 Jun 2026 | 34,623 | 666,404 | - | 78.9 | 2,730,024 | Class A Common Stock |
| Health Catalyst Inc | Benjamin Albert | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.69 per share. | 10 Jun 2026 | 34,485 | 1,423,971 (3%) | 0% | 1.7 | 58,342 | Common Stock |
| CryoPort Inc | Edward J. Zecchini | Chief Digital and Tech Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 33,600 | 0 | - | - | Stock Option (right to buy) | |
| CryoPort Inc | Edward J. Zecchini | Chief Digital and Tech Officer | Sale of securities on an exchange or to another person at price $ 14.47 per share. | 10 Jun 2026 | 33,600 | 109,719 (0%) | 0% | 14.5 | 486,239 | Common Stock |
| CryoPort Inc | Edward J. Zecchini | Chief Digital and Tech Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.80 per share. | 10 Jun 2026 | 33,600 | 143,319 (0%) | 0% | 4.8 | 161,280 | Common Stock |
| Krispy Kreme Inc | David J. Deno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 33,334 | 184,845 | - | 0 | Common Stock | |
| Krispy Kreme Inc | Patrick J. Grismer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 33,334 | 81,129 | - | 0 | Common Stock | |
| Krispy Kreme Inc | Easwaran Sundaram | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 33,334 | 81,129 | - | 0 | Common Stock | |
| Cytek BioSciences Inc | Deborah J. Neff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 33,333 | 33,333 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Richard Chin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 33,333 | 33,333 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Michael Holder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 33,333 | 33,333 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Vera Imper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 33,333 | 33,333 | - | - | Restricted Stock Units | |
| Pure Storage Inc (Class A) | John Colgrove | Director, Chief Visionary Officer | Sale of securities on an exchange or to another person at price $ 71.54 per share. | 10 Jun 2026 | 32,833 | 2,615,000 (1%) | 0% | 71.5 | 2,348,873 | Class A Common Stock |
| Pure Storage Inc (Class A) | John Colgrove | Director, Chief Visionary Officer | Sale of securities on an exchange or to another person at price $ 71.54 per share. | 10 Jun 2026 | 32,768 | 2,615,000 (1%) | 0% | 71.5 | 2,344,223 | Class A Common Stock |
| Weave Comm Inc | George P. Scanlon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 32,502 | 153,681 | - | 0 | Common Stock | |
| Weave Comm Inc | Adrian McDermott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 32,502 | 76,249 | - | 0 | Common Stock | |
| Weave Comm Inc | Tyler Newton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 32,502 | 124,677 | - | 0 | Common Stock | |
| Weave Comm Inc | Debora Beachner Tomlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 32,502 | 124,677 | - | 0 | Common Stock | |
| Weave Comm Inc | Stuart C. Harvey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 32,502 | 127,337 | - | 0 | Common Stock | |
| Weave Comm Inc | David Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 32,502 | 125,106 | - | 0 | Common Stock | |
| Alphatec Holdings Inc | Keith C. Valentine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 32,012 | 264,283 (0%) | 0% | 0 | Common Stock | |
| Alphatec Holdings Inc | Karen K. McGinnis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 32,012 | 100,721 (0%) | 0% | 0 | Common Stock | |
| Alphatec Holdings Inc | Quentin S. Blackford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 32,012 | 600,381 (0%) | 0% | 0 | Common Stock | |
| Alphatec Holdings Inc | David R. Pelizzon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 32,012 | 378,839 (0%) | 0% | 0 | Common Stock | |
| Seadrill Ltd | Todd D. Strickler | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 44.69 per share. | 10 Jun 2026 | 31,409 | 0 | - | 44.7 | 1,403,668 | Common Shares |
| Payoneer Global Inc | Christopher P. Marshall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 31,298 | 65,586 | - | 0 | Common Stock | |
| Payoneer Global Inc | Pamela H. Patsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 31,298 | 240,818 | - | 0 | Common Stock | |
| Payoneer Global Inc | Barak Eilam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 31,298 | 66,162 | - | 0 | Common Stock | |
| Payoneer Global Inc | Rich Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 31,298 | 235,791 | - | 0 | Common Stock | |
| Payoneer Global Inc | Sharda Caro del Castillo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 31,298 | 142,339 | - | 0 | Common Stock | |
| Payoneer Global Inc | Amir Goldman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 31,298 | 87,225 | - | 0 | Common Stock | |
| Payoneer Global Inc | Susanna Morgan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 31,298 | 141,354 | - | 0 | Common Stock | |
| Remitly Global Inc | Nigel W. Morris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 30,556 | 1,890,994 | - | 0 | Common Stock | |
| Remitly Global Inc | Bora Chung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 30,556 | 159,325 | - | 0 | Common Stock | |
| Remitly Global Inc | Laurent Le Moal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 30,556 | 92,151 | - | 0 | Common Stock | |
| Figure Technology Solutions | Michael Scott Cagney | Director, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 10 Jun 2026 | 30,370 | 32,043,819 | - | - | Class B Common Stock | |
| Figure Technology Solutions | June Ou | Director, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 10 Jun 2026 | 30,370 | 32,043,819 | - | - | Class B Common Stock | |
| AMD | Lisa T. Su | Director, Chair, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jun 2026 | 30,000 | 2,866,899 (0%) | 0% | 0 | Common Stock | |
| Cytek BioSciences Inc | Glenn P. Muir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 29,835 | 29,835 | - | - | Director Stock Option (right to buy) | |
| Dutch Bros Inc (Class A) | Travis Boersma | Director, Executive Chairman of Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 64.10 per share. | 10 Jun 2026 | 29,135 | 4,514,630 | - | 64.1 | 1,867,685 | Class A Common Stock |
| Sound Fin Bancorp Inc | Rogelio Riojas | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jun 2026 | 28,916 | 7,427 (0%) | 1% | 0 | Common Stock | |
| Liquidia Corp | Stephen Bloch | Director | Sale of securities on an exchange or to another person at price $ 66.30 per share. | 10 Jun 2026 | 28,237 | 1,418,453 (5%) | 0% | 66.3 | 1,872,206 | Common Stock |
| WSFS Fin Corp | Rodger Levenson | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 27,730 | 0 | - | - | Employee Stock Option (right to buy) | |
| WSFS Fin Corp | Rodger Levenson | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.84 per share. | 10 Jun 2026 | 27,730 | 251,534 (0%) | 0% | 51.8 | 1,437,523 | Common Stock |
| Dutch Bros Inc (Class A) | Travis Boersma | Director, Executive Chairman of Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 61.08 per share. | 10 Jun 2026 | 27,413 | 5,003,575 | - | 61.1 | 1,674,378 | Class A Common Stock |
| Yext Inc | Hillary B. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 27,131 | 0 | - | - | Restricted Stock Unit | |
| Yext Inc | Hillary B. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 27,131 | 133,849 (0%) | 0% | - | Common Stock | |
| Yext Inc | Jesse Lipson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 27,131 | 460,219 (0%) | 0% | - | Common Stock | |
| Yext Inc | Jesse Lipson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 27,131 | 0 | - | - | Restricted Stock Unit | |
| Yext Inc | Mark S. Davis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 27,131 | 89,631 (0%) | 0% | - | Common Stock | |
| Yext Inc | Mark S. Davis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 27,131 | 0 | - | - | Restricted Stock Unit | |
| Elutia Inc (Class A) | C. Randal Mills | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 27,083 | 436,489 | - | - | Class A Common Stock | |
| Elutia Inc (Class A) | C. Randal Mills | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 27,083 | 216,666 | - | - | Restricted Stock Units | |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 95.89 per share. | 10 Jun 2026 | 26,763 | 34,776 | - | 95.9 | 2,566,189 | Class A Common Stock |
| MasterBrand Inc | Bruce A. Kendrick | EVP & Chief HR Officer | Sale of securities on an exchange or to another person at price $ 9.02 per share. | 10 Jun 2026 | 26,245 | 241,665 | - | 9.0 | 236,817 | Common Stock, par value $0.01 per share |
| Marvell Tech Inc | Daniel J. Durn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 25,877 | 25,877 | - | - | Restricted Stock Units | |
| Marvell Tech Inc | Daniel J. Durn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 25,877 | 25,877 | - | - | Restricted Stock Units | |
| Marvell Tech Inc | Daniel J. Durn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 25,877 | 25,877 | - | - | Restricted Stock Units | |
| Brady Corp (Class A) | Vineet A. Nargolwala | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 25,684 | 78,393 (0%) | 0% | 0 | Class A Common Stock | |
| Krispy Kreme Inc | Joseph James Esposito | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 25,642 | 128,351 | - | 0 | Common Stock | |
| Liquidia Corp | Stephen Bloch | Director | Sale of securities on an exchange or to another person at price $ 68.91 per share. | 10 Jun 2026 | 25,117 | 1,374,491 (4%) | 0% | 68.9 | 1,730,720 | Common Stock |
| Fennec Pharma Inc | Khalid Islam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 25,000 | 250,000 | - | - | Stock Option | |
| Fractyl Health Inc | Harith Rajagopalan | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.73 per share. | 10 Jun 2026 | 25,000 | 540,557 | - | 0.7 | 18,253 | Common Stock |
| Kiora Pharma Inc | Lisa Walters Hoffert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Kiora Pharma Inc | David A. Hollander | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Kiora Pharma Inc | Aron Shapiro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Kiora Pharma Inc | Erin Parsons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Kiora Pharma Inc | Carmine N. Stengone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Coca-Cola | Jennifer Kay Mann | Executive Vice President | Sale of securities on an exchange or to another person at price $ 83.41 per share. | 10 Jun 2026 | 23,984 | 157,400 (0%) | 0% | 83.4 | 2,000,594 | Common Stock, $.25 Par Value |
| Cinemark Holdings Inc | Wanda Marie Gierhart | Chief Marketing & Content Ofc | Sale or transfer of securities back to the company at price $ 33.00 per share. | 10 Jun 2026 | 23,456 | 67,532 (0%) | 0% | 33 | 774,048 | Common Stock |
| Heartflow Inc | John C.M. Farquhar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 28.50 per share. | 10 Jun 2026 | 22,562 | 496,835 | - | 28.5 | 643,017 | Common Stock |
| Fractyl Health Inc | Clive A. Meanwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 22,500 | 22,500 | - | - | Stock Option | |
| Fractyl Health Inc | Marc Elia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 22,500 | 22,500 | - | - | Stock Option | |
| Fractyl Health Inc | Ajay Royan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 22,500 | 22,500 | - | - | Stock Option | |
| Fractyl Health Inc | Kelly Ann Barnes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 22,500 | 22,500 | - | - | Stock Option | |
| Fractyl Health Inc | Samuel Conaway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 22,500 | 22,500 | - | - | Stock Option | |
| Fractyl Health Inc | Christopher Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 22,500 | 22,500 | - | - | Stock Option | |
| Planet Fitness Inc (Class A) | Colleen Keating | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.60 per share. | 10 Jun 2026 | 22,494 | 119,017 (0%) | 0% | 50.6 | 1,138,196 | Class A common stock |
| BioAge Labs Inc | Jean-Pierre Garnier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| BioAge Labs Inc | Patrick G. Enright | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| BioAge Labs Inc | James I. Healy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| BioAge Labs Inc | Michael Harvey Davidson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| BioAge Labs Inc | Rekha Hemrajani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Orthofix Medical Inc | Michael M. Finegan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 20,721 | 81,617 (0%) | 0% | 0 | Common Stock | |
| Schneider National Inc (Class B) | Thomas G. Jackson | EVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.91 per share. | 10 Jun 2026 | 20,271 | 97,445 (0%) | 0% | 25.9 | 525,222 | Class B Common Stock |
| Schneider National Inc (Class B) | Thomas G. Jackson | EVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 20,271 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Schneider National Inc (Class B) | Thomas G. Jackson | EVP - General Counsel | Sale of securities on an exchange or to another person at price $ 37.15 per share. | 10 Jun 2026 | 20,271 | 77,174 (0%) | 0% | 37.1 | 752,978 | Class B Common Stock |
| Liquidia Corp | Stephen Bloch | Director | Sale of securities on an exchange or to another person at price $ 71.07 per share. | 10 Jun 2026 | 20,208 | 1,268,998 (4%) | 0% | 71.1 | 1,436,124 | Common Stock |
| Palisade Bio Inc | Binxian Wei | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 20,200 | 40,400 | - | - | Restricted Stock Units | |
| Palisade Bio Inc | Binxian Wei | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 20,200 | 613,355 | - | - | Common Stock | |
| Palisade Bio Inc | Emil Chuang | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 20,200 | 612,500 | - | - | Common Stock | |
| Palisade Bio Inc | Emil Chuang | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 20,200 | 40,400 | - | - | Restricted Stock Units | |
| MediaAlpha Inc (Class A) | Eugene Nonko | Director | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 10 Jun 2026 | 20,001 | 1,227,273 | - | 10.0 | 200,034 | Class A Common Stock |
| Fennec Pharma Inc | Chris A. Rallis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 20,000 | 200,000 | - | - | Stock Option | |
| Fennec Pharma Inc | Marco M. Brughera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 20,000 | 235,545 | - | - | Stock Option | |
| Fennec Pharma Inc | Jodi A. Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 20,000 | 160,000 | - | - | Stock Options | |
| Lifeway Foods Inc | Ludmila Smolyansky | Member of 10% owner group | Sale of securities on an exchange or to another person at price $ 24.02 per share. | 10 Jun 2026 | 20,000 | 692,823 (4%) | 0% | 24.0 | 480,400 | Common Stock, no par value |
| Texas Community Bancshares Inc | Anthony R. Scavuzzo | Director | Purchase of securities on an exchange or from another person at price $ 17.25 per share. | 10 Jun 2026 | 20,000 | 106,065 | - | 17.3 | 345,000 | Common Stock |
| Pebblebrook Hotel Trust | Jon E. Bortz | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 17.23 per share. | 10 Jun 2026 | 20,000 | 1,617,110 (1%) | 0% | 17.2 | 344,600 | Common Shares |
| Pebblebrook Hotel Trust | Jon E. Bortz | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 17.73 per share. | 10 Jun 2026 | 20,000 | 1,637,110 (1%) | 0% | 17.7 | 354,600 | Common Shares |
| Credo Tech Grp Holding Ltd | William Brennan | Director, Pres & Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 237.68 per share. | 10 Jun 2026 | 19,675 | 347,652 | - | 237.7 | 4,676,354 | Ordinary Shares |
| Lumexa Imaging Holdings Inc | Glenn A. Eisenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 19,358 | 19,358 | - | 0 | Common Stock | |
| Lumexa Imaging Holdings Inc | Molly E. Joseph | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 19,358 | 46,385 | - | 0 | Common Stock | |
| Lumexa Imaging Holdings Inc | Bridget E. Karlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 19,358 | 19,358 | - | 0 | Common Stock | |
| Lumexa Imaging Holdings Inc | Matthew Lungren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 19,358 | 19,358 | - | 0 | Common Stock | |
| Lumexa Imaging Holdings Inc | Robert Mittl | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 19,358 | 19,358 | - | 0 | Common Stock | |
| Slide Insurance Holdings Inc | Shannon Lucas | Director, President & COO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 17.03 per share. | 10 Jun 2026 | 19,058 | 1,123,415 | - | 17.0 | 324,558 | Common Stock |
| Monster Beverage | Guy P. Carling | CEO, EMEA and OSP | Sale of securities on an exchange or to another person at price $ 90.90 per share. | 10 Jun 2026 | 19,000 | 21,863 (0%) | 0% | 90.9 | 1,727,100 | Common Stock |
| Entrada Therapeutics Inc | Peter S. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
| Entrada Therapeutics Inc | Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
| Entrada Therapeutics Inc | Kush M. Parmar | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
| Entrada Therapeutics Inc | Mahalakshmi Radhakrishnan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
| Entrada Therapeutics Inc | Bernhardt G. Zeiher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
| Entrada Therapeutics Inc | Gina Chapman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
| Adamas Trust Inc | Michael B. Clement | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 18,678 | 0 | - | - | Deferred Stock Units | |
| Adamas Trust Inc | Michael B. Clement | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 18,678 | 101,309 (0%) | 0% | - | Common Stock, par value $0.01 per share | |
| Cytek BioSciences Inc | Deborah J. Neff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 18,261 | 18,261 | - | - | Director Stock Option (right to buy) | |
| Cytek BioSciences Inc | Richard Chin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 18,261 | 18,261 | - | - | Director Stock Option (right to buy) | |
| Cytek BioSciences Inc | Michael Holder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 18,261 | 18,261 | - | - | Director Stock Option (right to buy) | |
| Cytek BioSciences Inc | Vera Imper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 18,261 | 18,261 | - | - | Director Stock Option (right to buy) | |
| Fortrea Holdings Inc | David R. Smith | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.34 per share. | 10 Jun 2026 | 18,244 | 30,117 | - | 16.3 | 298,107 | Common Stock |
| Roku Inc (Class A) | Anthony Wood | Director, CEO and Chairman BOD, Ten Percent Owner | 10 Jun 2026 | 18,000 | 18,000 (0%) | 0% | - | Class A Common Stock | ||
| Roku Inc (Class A) | Anthony Wood | Director, CEO and Chairman BOD, Ten Percent Owner | 10 Jun 2026 | 18,000 | 16,175,111 | - | - | Class B Common Stock | ||
| Ziff Davis Inc | Bret Richter | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 46.88 per share. | 10 Jun 2026 | 18,000 | 29,244 (0%) | 0% | 46.9 | 843,840 | Common Stock $0.01 Par Value |
| Devon Energy | Andrea M. Alexander | SVP & CHIEF ADMIN OFFICER | Sale of securities on an exchange or to another person at price $ 46.74 per share. | 10 Jun 2026 | 18,000 | 138,529 (0%) | 0% | 46.7 | 841,320 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 75.00 per share. | 10 Jun 2026 | 17,566 | 73,411 (0%) | 0% | 75 | 1,317,450 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 10 Jun 2026 | 17,566 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.01 per share. | 10 Jun 2026 | 17,566 | 90,977 (0%) | 0% | 18.0 | 316,364 | Common Stock |
| Marriott | J. W. Marriott | Ten Percent Owner, 13D Group Owning more than 10% | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jun 2026 | 17,500 | 2,540,056 (0%) | 0% | 0 | Class A Common Stock | |
| Nike | Philip McCartney | EVP: CHIEF INN,PROD&DSG OFCR | Sale of securities on an exchange or to another person at price $ 46.18 per share. | 10 Jun 2026 | 17,398 | 53,132 (0%) | 0% | 46.2 | 803,440 | Class B Common Stock |
| Liquidia Corp | Stephen Bloch | Director | Sale of securities on an exchange or to another person at price $ 67.90 per share. | 10 Jun 2026 | 17,369 | 1,399,608 (4%) | 0% | 67.9 | 1,179,414 | Common Stock |
| Pure Storage Inc (Class A) | John Colgrove | Director, Chief Visionary Officer | Sale of securities on an exchange or to another person at price $ 70.08 per share. | 10 Jun 2026 | 17,167 | 2,647,833 (1%) | 0% | 70.1 | 1,203,063 | Class A Common Stock |
| Pure Storage Inc (Class A) | John Colgrove | Director, Chief Visionary Officer | Sale of securities on an exchange or to another person at price $ 70.08 per share. | 10 Jun 2026 | 17,132 | 2,647,768 (1%) | 0% | 70.1 | 1,200,611 | Class A Common Stock |
| Box Inc (Class A) | Dylan C. Smith | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 26.00 per share. | 10 Jun 2026 | 17,000 | 1,364,049 (0%) | 0% | 26.0 | 441,966 | Class A Common Stock |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 96.59 per share. | 10 Jun 2026 | 16,936 | 17,840 | - | 96.6 | 1,635,782 | Class A Common Stock |
| Applovin Corp (Class A) | Adam Foroughi | Director, CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jun 2026 | 16,667 | 2,411,017 | - | 0 | Class A Common Stock | |
| BJ`s Wholesale Club Holdings Inc | Scott Schmadeke | EVP, Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 92.17 per share. | 10 Jun 2026 | 16,500 | 20,471 (0%) | 0% | 92.2 | 1,520,805 | Common Stock |
| Rocket Companies Inc (Class A) | Jonathan D. Mariner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 16,312 | 102,300 | - | 0 | Class A common stock | |
| Rocket Companies Inc (Class A) | Suzanne F. Shank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 16,312 | 119,558 | - | 0 | Class A common stock | |
| Rocket Companies Inc (Class A) | Alastair Rampell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 16,312 | 54,639 | - | 0 | Class A common stock | |
| Porch Group Inc Ordinary | Maurice Tulloch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 15,940 | 141,706 | - | 0 | Common Stock | |
| Porch Group Inc Ordinary | Rachel Lam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 15,940 | 193,931 | - | 0 | Common Stock | |
| Porch Group Inc Ordinary | Alan R. Pickerill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 15,940 | 198,356 | - | 0 | Common Stock | |
| Porch Group Inc Ordinary | Regi Vengalil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 15,940 | 181,843 | - | 0 | Common Stock | |
| Porch Group Inc Ordinary | Sean Kell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 15,940 | 313,647 | - | 0 | Common Stock | |
| Porch Group Inc Ordinary | Amanda Reierson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 15,940 | 167,315 | - | 0 | Common Stock | |
| Porch Group Inc Ordinary | Camilla Velasquez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 15,940 | 219,291 | - | 0 | Common Stock | |
| Serve Robotics Inc | Ali Kashani | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 7.24 per share. | 10 Jun 2026 | 15,885 | 3,278,091 | - | 7.2 | 115,007 | Common Stock |
| NexPoint Diversified Real Estate Trust | Matt McGraner | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.07 per share. | 10 Jun 2026 | 15,849 | 338,420 (0%) | 0% | 5.1 | 80,354 | Common Stock |
| Vertex Inc (Class A) | Bradley M. Gayton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 15,638 | 68,500 | - | 0 | Class A Common Stock | |
| Vertex Inc (Class A) | Eric C. Andersen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 15,638 | 165,979 | - | 0 | Class A Common Stock | |
| Vertex Inc (Class A) | David DeStefano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 15,638 | 1,271,155 | - | 0 | Class A Common Stock | |
| Vertex Inc (Class A) | J. Richard Stamm | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 15,638 | 32,685 | - | 0 | Class A Common Stock | |
| Vertex Inc (Class A) | Amanda Westphal Radcliffe | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 15,638 | 159,030 | - | 0 | Class A Common Stock | |
| Vertex Inc (Class A) | Stefanie Westphal Thompson | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 15,638 | 66,995 | - | 0 | Class A Common Stock | |
| Vertex Inc (Class A) | Mark J. Mendola | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 15,638 | 20,965 | - | 0 | Class A Common Stock | |
| Dutch Bros Inc (Class A) | Travis Boersma | Director, Executive Chairman of Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 64.10 per share. | 10 Jun 2026 | 15,555 | 2,410,800 | - | 64.1 | 997,145 | Class A Common Stock |
| BlackSky Tech Inc (Class A) | Brian E. O'Toole | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 34.10 per share. | 10 Jun 2026 | 15,512 | 1,139,676 | - | 34.1 | 528,959 | Class A Common Stock |
| Tillys Inc (Class A) | Seth R. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 15,444 | 174,363 (0%) | 0% | 0 | Class A Common Stock | |
| Tillys Inc (Class A) | Douglas P. Collier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 15,444 | 152,511 (0%) | 0% | 0 | Class A Common Stock | |
| Tillys Inc (Class A) | Janet E. Kerr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 15,444 | 89,526 (0%) | 0% | 0 | Class A Common Stock | |
| Tillys Inc (Class A) | Michael Relich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 15,444 | 81,018 (0%) | 0% | 0 | Class A Common Stock | |
| Tillys Inc (Class A) | Teresa L. Aragones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 15,444 | 119,110 (0%) | 0% | 0 | Class A Common Stock | |
| Ocular Therapeutix Inc | Jason Shand Robins | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 15,441 | 68,097 (0%) | 0% | 0 | Common Stock | |
| WSFS Fin Corp | Rodger Levenson | President & CEO | Sale of securities on an exchange or to another person at price $ 74.43 per share. | 10 Jun 2026 | 15,406 | 186,088 (0%) | 0% | 74.4 | 1,146,669 | Common Stock |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | 10 Jun 2026 | 15,385 | 2,917,150 | - | - | Class B Common Stock | ||
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | 10 Jun 2026 | 15,385 | 15,385 | - | - | Class A Common Stock | ||
| Rapport Therapeutics Inc | John M. Maraganore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 15,200 | 15,200 | - | - | Stock Option (Right to Buy) | |
| Rapport Therapeutics Inc | Robert J. Perez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 15,200 | 15,200 | - | - | Stock Option (Right to Buy) | |
| Rapport Therapeutics Inc | Steven M. Paul | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 15,200 | 15,200 | - | - | Stock Option (Right to Buy) | |
| Rapport Therapeutics Inc | James I. Healy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 15,200 | 15,200 | - | - | Stock Option (Right to Buy) | |
| Rapport Therapeutics Inc | Paul M. Silva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 15,200 | 15,200 | - | - | Stock Option (Right to Buy) | |
| Rapport Therapeutics Inc | Reid M. Huber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 15,200 | 15,200 | - | - | Stock Option (Right to Buy) | |
| Rapport Therapeutics Inc | Ramiro Sanchez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 15,200 | 15,200 | - | - | Stock Option (Right to Buy) | |
| Rapport Therapeutics Inc | Wendy B. Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 15,200 | 15,200 | - | - | Stock Option (Right to Buy) | |
| Business First Bancshares Inc | George W Cummings | Director | Sale of securities on an exchange or to another person at price $ 28.89 per share. | 10 Jun 2026 | 15,000 | 266,180 (1%) | 0% | 28.9 | 433,350 | COMMON STOCK |
| Mobia Medical Inc | Prashant Rawat | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 15,000 | 182,243 | - | - | Stock Option | |
| Mobia Medical Inc | Prashant Rawat | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.38 per share. | 10 Jun 2026 | 15,000 | 15,000 | - | 3.4 | 50,700 | Common Stock |
| Orthofix Medical Inc | Jason M. Hannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 14,965 | 87,662 (0%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Vickie L. Capps | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 14,965 | 43,300 (0%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 14,965 | 105,774 (0%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Alan L. Bazaar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 14,965 | 65,489 (0%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Charles R. Kummeth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 14,965 | 76,305 (0%) | 0% | 0 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.